ha 1004 has been researched along with naloxone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavaliers, M; Ossenkopp, KP; Tysdale, DM | 1 |
| Laorden, ML; Martínez, MD; Milanés, MV | 1 |
| Almela, P; Cerezo, M; González-Cuello, A; Laorden, ML; Milanés, MV | 1 |
| Almela, P; Laorden, M; Milanés, M | 1 |
| Almela, P; Atucha, NM; Laorden, ML; Milanés, MV | 1 |
5 other study(ies) available for ha 1004 and naloxone
| Article | Year |
|---|---|
Evidence for the involvement of protein kinase C in the modulation of morphine-induced 'analgesia' and the inhibitory effects of exposure to 60-Hz magnetic fields in the snail, Cepaea nemoralis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Analgesia; Animals; Enzyme Activation; Hot Temperature; Isoquinolines; Magnetics; Morphine; Naloxone; Piperazines; Protein Kinase C; Snails; Sulfonamides | 1991 |
Implication of the signal transduction pathways in the enhancement of noradrenaline turnover induced by morphine withdrawal in the heart.
Topics: Animals; Calcium Channels, L-Type; Calcium Signaling; Cyclic AMP-Dependent Protein Kinases; Drug Combinations; Drug Implants; Heart; Infusion Pumps, Implantable; Injections, Subcutaneous; Isoquinolines; Male; Morphine; Morphine Dependence; Naloxone; Naphthalenes; Nimodipine; Norepinephrine; Normetanephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance Withdrawal Syndrome; Sulfonamides; Up-Regulation | 2003 |
Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
Topics: Animals; Blotting, Western; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Drug Implants; Immunochemistry; Infusions, Intravenous; Injections, Subcutaneous; Isoquinolines; Male; Morphine; Myocardium; Naloxone; Narcotic Antagonists; Narcotics; Norepinephrine; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Sulfonamides; Tyrosine 3-Monooxygenase | 2007 |
The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts.
Topics: Aminoacetonitrile; Animals; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Drug Implants; Isoquinolines; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morphine; Morphine Dependence; Myocardium; Naloxone; Naphthalenes; Narcotic Antagonists; Norepinephrine; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Serine; Substance Withdrawal Syndrome; Sulfonamides; Tyrosine 3-Monooxygenase | 2008 |
Cross-talk between protein kinase A and mitogen-activated protein kinases signalling in the adaptive changes observed during morphine withdrawal in the heart.
Topics: Adaptation, Physiological; Aminoacetonitrile; Analgesics, Opioid; Animals; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart; Hemodynamics; Isoquinolines; Male; Mitogen-Activated Protein Kinases; Morphine; Naloxone; Naphthalenes; Narcotic Antagonists; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance Withdrawal Syndrome; Sulfonamides; Tyrosine 3-Monooxygenase; Weight Gain | 2009 |